Guidelines for prescribing combined oral contraceptives.
作者信息
Mills A M, Wilkinson C L, Bromham D R, Elias J, Fotherby K, Guillebaud J, Kubba A, Wade A
出版信息
BMJ. 1996 Jan 13;312(7023):121-2. doi: 10.1136/bmj.312.7023.121a.
Abstract
摘要
相似文献
1
Guidelines for prescribing combined oral contraceptives.复方口服避孕药处方指南。
BMJ. 1996 Jan 13;312(7023):121-2. doi: 10.1136/bmj.312.7023.121a.
2
3
4
Desogestrel, gestodene contraceptives may carry greater thromboembolic risk.去氧孕烯、孕二烯酮避孕药可能具有更高的血栓栓塞风险。
Am J Health Syst Pharm. 1996 Feb 1;53(3):228. doi: 10.1093/ajhp/53.3.228a.
5
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.第三代口服避孕药与静脉血栓栓塞性疾病风险：一项国际病例对照研究。口服避孕药与年轻女性健康跨国研究小组。
BMJ. 1996 Jan 13;312(7023):83-8. doi: 10.1136/bmj.312.7023.83.
6
Scare over oral contraceptives. Studies implicate only gestodene and desogestrel.口服避孕药引发恐慌。研究表明仅孕二烯酮和去氧孕烯有此关联。
BMJ. 1995 Dec 16;311(7020):1639. doi: 10.1136/bmj.311.7020.1639b.
7
Risk of acute myocardial infarction and low-dose combined oral contraceptives.急性心肌梗死风险与低剂量复方口服避孕药
Lancet. 1996 Mar 2;347(9001):627-8. doi: 10.1016/s0140-6736(96)91334-3.
8
Oral contraceptives and venous thromboembolism.口服避孕药与静脉血栓栓塞症
Lancet. 1995 Nov 25;346(8987):1430.
9
Third generation oral contraceptives--the controversy.第三代口服避孕药——争议
BMJ. 1995 Dec 16;311(7020):1589-90. doi: 10.1136/bmj.311.7020.1589.
10
[Third-generation oral contraceptives--how big is the risk of venous thrombosis?].[第三代口服避孕药——静脉血栓形成的风险有多大？]
Tidsskr Nor Laegeforen. 2004 Jun 3;124(11):1521-2.
引用本文的文献
1
How to communicate evidence to patients.如何向患者传达证据。
Drug Ther Bull. 2019 Aug;57(8):119-124. doi: 10.1136/dtb.2019.000008.
2
Diane-35 (cyproterone acetate): safety concerns.达英-35（醋酸环丙孕酮）：安全性问题。
CMAJ. 2003 Feb 18;168(4):455-6.
本文引用的文献
1
Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.第三代口服避孕药与心肌梗死风险：一项国际病例对照研究。口服避孕药与年轻女性健康跨国研究小组。
BMJ. 1996 Jan 13;312(7023):88-90. doi: 10.1136/bmj.312.7023.88.
2
Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.第三代口服避孕药与静脉血栓栓塞性疾病风险：一项国际病例对照研究。口服避孕药与年轻女性健康跨国研究小组。
BMJ. 1996 Jan 13;312(7023):83-8. doi: 10.1136/bmj.312.7023.83.
3
Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.携带第三代孕激素的口服避孕药所致深静脉血栓形成风险因凝血因子V莱顿突变而增加。
Lancet. 1995 Dec 16;346(8990):1593-6. doi: 10.1016/s0140-6736(95)91929-5.
4
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.使用含不同孕激素成分口服避孕药的女性发生特发性心血管死亡和非致命性静脉血栓栓塞的风险。
Lancet. 1995 Dec 16;346(8990):1589-93. doi: 10.1016/s0140-6736(95)91928-7.
Zotero 插件